|
Volumn 19, Issue 9, 2012, Pages 1080-1082
|
Fine-tuning S1P therapeutics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 [2 (3 TRIFLUOROMETHYL 4 BIPHENYLYL)BENZO[B]THIEN 5 YLMETHYLAMINO]PROPIONIC ACID;
5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE;
AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;
CYM 5442;
EXEL 4541;
FINGOLIMOD;
IMMUNOMODULATING AGENT;
NIBR 0213;
ONO 4641;
PONESIMOD;
SPHINGOSINE 1 PHOSPHATE RECEPTOR;
SPHINGOSINE 1 PHOSPHATE RECEPTOR 1;
TASP0277308;
UNCLASSIFIED DRUG;
VPC44116;
W146;
ALLERGIC ENCEPHALOMYELITIS;
ARTICLE;
BLOOD VESSEL FUNCTION;
BRADYCARDIA;
CELL MIGRATION;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
HEART RATE;
HUMAN;
MULTIPLE SCLEROSIS;
NONHUMAN;
PROTEIN FUNCTION;
PULMONARY VASCULAR DISEASE;
PULMONARY VASCULAR LEAKAGE;
|
EID: 84866679097
PISSN: 10745521
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chembiol.2012.09.002 Document Type: Short Survey |
Times cited : (9)
|
References (11)
|